Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American Journal on Addictions

• Publication date

  2017-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ajad.12622PMID 28921814PMCID PMC5699926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Welfare-to-work interventions and their effects on the mental and physical health of lone parents and their children.

  2017cited by this paper
• A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

  2017cited by this paper
• Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health

  2017cited by this paper
• Vilazodone for cannabis dependence: A randomized, controlled pilot trial.

  2016cited by this paper
• Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users

  2016cited by this paper
• Marijuana use and use disorders in adults in the USA, 2002-14: analysis of annual cross-sectional surveys.

  2016cited by this paper
• Adverse health effects of marijuana use.

  2014cited by this paper
• Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.

  2014cited by this paper
• Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use.

  2014cited by this paper
• Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse

  2013cited by this paper
• A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.

  2012cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2012cited by this paper
• A Proof-of-Concept Randomized Controlled Study of Gabapentin: Effects on Cannabis Use, Withdrawal and Executive Function Deficits in Cannabis-Dependent Adults

  2012cited by this paper
• Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

  2011cited by this paper
• Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.

  2011cited by this paper
• Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.

  2011cited by this paper
• Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

  2011cited by this paper
• A placebo-controlled trial of buspirone for the treatment of marijuana dependence.

  2009cited by this paper
• Reliability and validity of a short form of the Marijuana Craving Questionnaire.

  2009cited by this paper
• A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.

  2009cited by this paper
• Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

  2009cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2008cited by this paper
• Pharmacologic treatments for opioid dependence: detoxification and maintenance options

  2007cited by this paper
• Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

  2006cited by this paper
• Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

  2006cited by this paper
• Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium.

  2004cited by this paper
• The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.

  2003cited by this paper
• Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans

  2001cited by this paper
• Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio study.

  1999cited by this paper
• Urinary Excretion Profiles of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol: A Δ9-THCCOOH to Creatinine Ratio Study

  1999cited by this paper
• Naltrexone and alcohol dependence. Role of subject compliance.

  1997cited by this paper
• Reliability and validity of the beck anxiety inventory

  1992cited by this paper
• A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

  1965cited by this paper

• Feasibility and Tolerability of Nabilone for the Treatment of Obesity: A Randomized Controlled Pilot Trial

  2025cites this paper
• The differential effects of medicinal cannabis on mental health: A systematic review.

  2025cites this paper
• Pharmacotherapies for cannabis use disorder.

  2025cites this paper
• Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action

  2024cites this paper
• Addiction and Liver Disease: Exploring the Complex Relationship and Implications for Clinical Management

  2024cites this paper
• Unravelling the landscape of Cannabis craving pharmacological treatments: a PRISMA-guided review of evidence

  2023cites this paper
• Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials

  2022cites this paper
• Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study

  2022cites this paper
• Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders

  2022cites this paper
• The “Next Day” Effects of Cannabis Use: A Systematic Review

  2022cites this paper
• A Systemic Review of Medical Cannabinoids Dosing in Human.

  2022cites this paper
• Review: Cannabinoids as Medicinals

  2022cites this paper
• Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

  2022cites this paper
• Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders

  2022cites this paper
• Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials.

  2021cites this paper
• Cannabis use and cannabis use disorder

  2021cites this paper
• The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization.

  2021cites this paper
• Untapped endocannabinoid pharmacological targets: pipe dream or pipeline?

  2021cites this paper
• Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis.

  2021cites this paper
• Cannabinoid Drugs in Mental Health Disorders

  2021cites this paper
• Clinical management of cannabis withdrawal

  2021cites this paper
• Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth?

  2021cites this paper
• Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.

  2021cites this paper
• Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists.

  2021cites this paper
• Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder

  2020cites this paper
• Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness?

  2020cites this paper
• The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

  2020cites this paper
• Standard and Precordial Leads Obtained With an Apple Watch

  2020influential citation
• Care of the Patient Using Cannabis

  2020cites this paper
• A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis

  2019cites this paper
• Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder.

  2019cites this paper
• Cannabis and the Current State of Treatment for Cannabis Use Disorder.

  2019cites this paper
• Medicinal Use of Synthetic Cannabinoids—a Mini Review

  2019cites this paper
• Denoising scanner effects from multimodal MRI data using linked independent component analysis

  2019cites this paper
• The role of cannabis in treating anxiety: an update.

  2019cites this paper
• Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: A population-based cohort study.

  2019cites this paper
• Cannabinoids to Treat Cannabis Use Disorders

  2018cites this paper
• Combining Multi-Site/Multi-Study MRI Data: Linked-ICA Denoising for Removing Scanner and Site Variability from Multimodal MRI Data

  2018cites this paper
• The Molecular Basis of Cannabinoid Activity: Application to Therapeutics Design and Discovery for Cannabis Use Disorders

  2018cites this paper
• Cannabis and Mood Disorders

  2018cites this paper